Literature DB >> 23872121

Biochemical and preliminary X-ray characterization of the tumor-associated calcium signal transducer 2 (Trop2) ectodomain.

Tilen Vidmar1, Miha Pavšič, Brigita Lenarčič.   

Abstract

Trop2 is a stem/progenitor cell marker, which is also upregulated in several human carcinomas. The largest part of the molecule, recognized by several monoclonal antibodies, is represented by the extracellular part (ectodomain) and is composed of three modules. The aim of our work was to prepare the ectodomain of Trop2 in quantities sufficient for structural and functional studies. We used the Spodoptera frugiperda (Sf9) insect cell expression system to prepare the Trop2 ectodomain (Trop2EC) in two forms - wt glycosylated (gTrop2EC) and mutant non-glycosylated form (Trop2EC(Δ/N)). Recombinant protein was purified from cell culture supernatants using two subsequent nickel ion-affinity chromatographies with a final yield of 15-17mg of purified recombinant protein per liter of culture. Size-exclusion chromatography together with MALS and chemical crosslinking were used to demonstrate for the first time that the Trop2 ectodomain forms a dimer. Both gTrop2EC and Trop2EC(Δ/N) exhibit similar biochemical properties, however the solubility of Trop2EC(Δ/N) is much lower (less than 1mg/ml). For the purpose of structural studies, we crystallized the glycosylated form gTrop2EC. The native dataset was collected with a resolution of 2.94Å and will be used in ongoing work for phasing and structure solution to further understand the role of Trop2 and the structure-function relation between Trop2 and the epithelial cell adhesion molecule (EpCAM).
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dimer; EpCAM; Extracellular domain; MultiBac; N-Glycosylation; Protein crystallization; Sf9 insect cells

Mesh:

Substances:

Year:  2013        PMID: 23872121     DOI: 10.1016/j.pep.2013.07.006

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  10 in total

1.  Rapid fine conformational epitope mapping using comprehensive mutagenesis and deep sequencing.

Authors:  Caitlin A Kowalsky; Matthew S Faber; Aritro Nath; Hailey E Dann; Vince W Kelly; Li Liu; Purva Shanker; Ellen K Wagner; Jennifer A Maynard; Christina Chan; Timothy A Whitehead
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

2.  The cytosolic tail of the tumor marker protein Trop2--a structural switch triggered by phosphorylation.

Authors:  Miha Pavšič; Gregor Ilc; Tilen Vidmar; Janez Plavec; Brigita Lenarčič
Journal:  Sci Rep       Date:  2015-05-18       Impact factor: 4.379

Review 3.  Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications.

Authors:  Anna Shvartsur; Benjamin Bonavida
Journal:  Genes Cancer       Date:  2015-03

4.  Trop2 is overexpressed in gastric cancer and predicts poor prognosis.

Authors:  Wei Zhao; Huijun Zhu; Shu Zhang; Hongmei Yong; Wei Wang; Yan Zhou; Bing Wang; Jinbo Wen; Zhenning Qiu; Guipeng Ding; Zhenqing Feng; Jin Zhu
Journal:  Oncotarget       Date:  2016-02-02

5.  Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential.

Authors:  Hany E Marei; A Althani; S Lashen; C Cenciarelli; Anwarul Hasan
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

Review 6.  The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target.

Authors:  David M Goldenberg; Rhona Stein; Robert M Sharkey
Journal:  Oncotarget       Date:  2018-06-22

7.  Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins.

Authors:  Chuan-Jin Wu; Michael Lu; Xu Feng; Gaku Nakato; Mark C Udey
Journal:  Cells       Date:  2020-04-21       Impact factor: 6.600

Review 8.  Trop2: Jack of All Trades, Master of None.

Authors:  Sára Lenárt; Peter Lenárt; Jan Šmarda; Ján Remšík; Karel Souček; Petr Beneš
Journal:  Cancers (Basel)       Date:  2020-11-11       Impact factor: 6.639

9.  Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer.

Authors:  Shuhei Kushiyama; Masakazu Yashiro; Yurie Yamamoto; Tomohiro Sera; Atsushi Sugimoto; Sadaaki Nishimura; Shingo Togano; Kenji Kuroda; Mami Yoshii; Tatsuro Tamura; Takahiro Toyokawa; Hiroaki Tanaka; Kazuya Muguruma; Hiroshi Nakada; Masaichi Ohira
Journal:  Mol Clin Oncol       Date:  2021-03-19

10.  Identification and Characterization of Specific Nanobodies against Trop-2 for Tumor Targeting.

Authors:  Yaozhong Hu; Yi Wang; Jing Lin; Sihao Wu; Huan Lv; Xuemeng Ji; Shuo Wang
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.